Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced Clinical trial data shows RAD 101 detects Brain Metastases Download the PDF here. This post appeared first on investingnews.com 0 Related Posts 5 Best-performing Canadian Cleantech Stocks of 2025 December 20, 2025 Denison and Skyharbour Finalize Saskatchewan Uranium JV Deal December 19, 2025 Spartan Metals Provides Encouraging Drill Assay Results for Tungstonia Tailings at its Eagle Project, Nevada December 18, 2025
Spartan Metals Provides Encouraging Drill Assay Results for Tungstonia Tailings at its Eagle Project, Nevada December 18, 2025